Greg Adams

Senior Director, Global Analytical Strategy & Development at FUJIFILM Diosynth Biotechnologies

Speaker

Greg has 30 years of experience in analytical development, specializing in the mass spectrometric characterization of protein based biopharmaceuticals. He received his doctorate from the University of Adelaide followed by postdoctoral research at the University of California, San Francisco. For the past twenty years, he has worked at FUJIFILM Diosynth Biotechnologies in analytical development supporting the characterization and method development of biotherapeutic proteins in clinical development and commercial production.